<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03722524</url>
  </required_header>
  <id_info>
    <org_study_id>IC4-06593-057-RUS</org_study_id>
    <nct_id>NCT03722524</nct_id>
  </id_info>
  <brief_title>The Use of TRIple Fixed-dose COmbination in the Treatment of arteriaL Hypertension: Opportunity for Effective BP Control With cOmbined Antihypertensive theRapy</brief_title>
  <acronym>TRICOLOR</acronym>
  <official_title>Multinational Observational Uncontrolled Open Programme &quot;The Use of TRIple Fixed-dose COmbination in the Treatment of arteriaL Hypertension: Opportunity for Effective BP Control With cOmbined Antihypertensive Therapy&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Servier Russia</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Servier Russia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The use of TRIple fixed-dose COmbination in the treatment of arteriaL hypertension:
      opportunity for effective BP control with cOmbined antihypertensive therapy.

      The main aim of this study to assess the antihypertensive effectiveness effect on the 24-hour
      BP profile, as well as tolerability of and compliance to the treatment with a triple FDC of
      amlodipine / indapamide / perindopril arginine in hypertensive patients in the real clinical
      practice.

      Type of program: Multicenter, observational, non-controlled, open-label program.

      Investigators: Cardiologists and outpatient (primary care) physicians (general
      practitioners).

      Number of patients: 1,300 hypertensive patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 30, 2018</start_date>
  <completion_date type="Anticipated">January 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The effectiveness of triple FDC of amlodipine / indapamide / perindopril arginine in terms of BP control in hypertensive patients from the real clinical practice.</measure>
    <time_frame>3 months</time_frame>
    <description>• Office BP and pulse rate measurements</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>• The 24-hour BP profile on the top of FDC of amlodipine / indapamide / perindopril arginine in hypertensive patients from the real clinical practice.</measure>
    <time_frame>3 months</time_frame>
    <description>• Ambulatory blood pressure monitoring (ABPM) (in those patients, in whom it is required, according to the decision of treating physician, based on his/her experience and established practice). The BP will be measured on the non-dominant arm. The measurements will be carried out every 15 minutes in the daytime from 7:00 to 23:00 and every 30 minutes in the nighttime from 23:00 to 7:00.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Tolerability of the triple FDC of amlodipine / indapamide / perindopril arginine in hypertensive patients from the real clinical practice.</measure>
    <time_frame>3 months</time_frame>
    <description>• Assessment of the treatment tolerability by completion of the standard pharmacovigilance form.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>• Compliance with the treatment with triple FDC of amlodipine / indapamide / perindopril arginine in hypertensive patients from the real clinical practice.</measure>
    <time_frame>3 months</time_frame>
    <description>• Assessment of the patient's compliance with the treatment will be carried out using the compliance questionnaire .</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1300</enrollment>
  <condition>Arterial Hypertension</condition>
  <arm_group>
    <arm_group_label>Patients with arterial hypertension</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>amlodipine / indapamide / perindopril arginine FDC</intervention_name>
    <description>CCB / diuretic / ACE inhibitor</description>
    <arm_group_label>Patients with arterial hypertension</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with uncontrolled arterial hypertension who needs triple antihypertensive
        combinations in a single tablet
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 to 79 years

          -  Essential hypertension

          -  Patient's consent to participate in the program

          -  Doctor's decision to prescribe FDC of amlodipine / indapamide / perindopril arginine,
             according to the instruction for use, prior to the inclusion in the program.

        Exclusion Criteria:

          -  Symptomatic, or secondary arterial hypertension

          -  Office BP ≥ 180/110 mm Hg on treatment (at V0 visit)

          -  History of myocardial infarction, unstable angina, or cerebrovascular accident within
             the past 1 year

          -  CHF of class III-IV NYHA

          -  Type I diabetes or decompensated type 2 diabetes

          -  Diseases with severe organ dysfunction (hepatic failure, renal failure, etc.)

          -  Contraindications to or known intolerance of dihydropyridine calcium channel blockers
             (including amlodipine) and/or indapamide and/or ACE inhibitors (including perindopril)
             and/or their fixed combination

          -  Inability to understand the nature of the program and/or to follow the doctor's
             recommendations, including ones for the BP self-monitoring.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yury Karpov, Prof</last_name>
    <phone>+7 495 414 68 46</phone>
    <email>yuri_karpov@inbox.ru</email>
  </overall_contact>
  <location>
    <facility>
      <name>City Policlinic #3</name>
      <address>
        <city>Almetyevsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Musluma Zakieva, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 9</name>
      <address>
        <city>Barnaul</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alexandr Kapitanov, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 7</name>
      <address>
        <city>Belgorod</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olga Kozjaicheva, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Hospital # 2</name>
      <address>
        <city>Brjansk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ekaterina Vozgrina, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 15</name>
      <address>
        <city>Chabarowsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marina Tishkina, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 8</name>
      <address>
        <city>Chelyabinsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Darja Voronina, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 2</name>
      <address>
        <city>Cherepovets</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olga Orlova, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 3</name>
      <address>
        <city>Ekaterinburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anisa Egorova, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 8</name>
      <address>
        <city>Irkutsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alexandra Leontieva, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 5</name>
      <address>
        <city>Ivanovo</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Natalya Vavilova, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Hospital # 1</name>
      <address>
        <city>Izhevsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marina Koroleva, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 1</name>
      <address>
        <city>Jaroslavl</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elena Emelianova, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 18</name>
      <address>
        <city>Kazan</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olga Romanova, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 5</name>
      <address>
        <city>Kemerovo</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anastasia Goncharenko, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 2</name>
      <address>
        <city>Kirov</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elena Konovalova, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 7</name>
      <address>
        <city>Krasnoyarsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elena Griboleva, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 7</name>
      <address>
        <city>Kursk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tatjana Bez, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>FSBI NMIC of Cardiology of the Ministry of Health of Russia</name>
      <address>
        <city>Moscow</city>
        <zip>121552</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuriy Karpov, prof</last_name>
      <phone>+7 495 414 68 46</phone>
      <email>yuri_karpov@inbox.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 70</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marina Cherkashina, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 2</name>
      <address>
        <city>Murmansk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ekaterina Boykova, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 17</name>
      <address>
        <city>Nizhniy Novgorod</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lidia Golubeva, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Hospital # 2</name>
      <address>
        <city>Novokuznetsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Margarita Lapenko, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 14</name>
      <address>
        <city>Novosibirsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Valentina Tarasova, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 2</name>
      <address>
        <city>Omsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Valeria Eremina, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinic PROM-MED</name>
      <address>
        <city>Orenburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Irina Galushko, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 2</name>
      <address>
        <city>Orël</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elena Gurova, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlinic of Regional Clinic Hospital</name>
      <address>
        <city>Penza</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Natalya Ivankina, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical Center &quot;Alfa-Center&quot;</name>
      <address>
        <city>Perm</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria Lazareva, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 4</name>
      <address>
        <city>Petrozavodsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Olga Vedeneeva, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 3</name>
      <address>
        <city>Pskov</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ekaterina Astafieva, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 42</name>
      <address>
        <city>Rostov-on-Don</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Oksana Bombina, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 2</name>
      <address>
        <city>Ryazan'</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alexandra Malashkina, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 8</name>
      <address>
        <city>Samara</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zoe Abramova, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 27</name>
      <address>
        <city>Sankt-Peterburg</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria Koroleva, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 2</name>
      <address>
        <city>Saratov</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elena Kalamina, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 2</name>
      <address>
        <city>Sevastopol</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tatiana Dubovik, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlinic of Russian railway</name>
      <address>
        <city>Smolensk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Igor Reshetov, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 2</name>
      <address>
        <city>Stary Oskol</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ludmila Kuznetsova, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 3</name>
      <address>
        <city>Syktyvkar</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elena Pfefer, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 6</name>
      <address>
        <city>Tambov</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elena Lukina, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 3</name>
      <address>
        <city>Tjumen</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ekaterina Volkova, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 2</name>
      <address>
        <city>Toljatti</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julia Janina, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 2</name>
      <address>
        <city>Tomsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alla Romashova, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlinic VIRMED</name>
      <address>
        <city>Tula</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elena Lazareva, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 46</name>
      <address>
        <city>Ufa</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elvira Edrisova, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 4</name>
      <address>
        <city>Veliky Novgorod</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Natalia Korotkova, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 4</name>
      <address>
        <city>Vladimir</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Kononova, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 4</name>
      <address>
        <city>Vladivostok</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Natalia Ichtonova, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 15</name>
      <address>
        <city>Volgograd</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Oksana Kobizskaja, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 3</name>
      <address>
        <city>Vologda</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Natalia Kuznezova, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>City Policlinic # 7</name>
      <address>
        <city>Voronezh</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lilia Baruzdina, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 22, 2018</study_first_submitted>
  <study_first_submitted_qc>October 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2018</study_first_posted>
  <last_update_submitted>October 10, 2019</last_update_submitted>
  <last_update_submitted_qc>October 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amlodipine</mesh_term>
    <mesh_term>Perindopril</mesh_term>
    <mesh_term>Indapamide</mesh_term>
    <mesh_term>Indapamide, perindopril drug combination</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

